Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 15, Issue 694, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2023-05-04
DOI
10.1126/scitranslmed.adf1128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer
- (2023) Mengdie Wang et al. Science Translational Medicine
- Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance
- (2022) Ridwan Islam et al. CANCER AND METASTASIS REVIEWS
- Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance
- (2022) Ridwan Islam et al. Cell Reports
- A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
- (2021) Shiyang Shen et al. Nature Nanotechnology
- N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling
- (2021) Li Wang et al. Frontiers in Oncology
- Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells
- (2021) Xuelong Wang et al. Frontiers in Cell and Developmental Biology
- Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
- (2021) Yves Boucher et al. npj Precision Oncology
- Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer
- (2020) Alexander Schulz et al. Frontiers in Oncology
- Translational control of breast cancer plasticity
- (2020) Michael Jewer et al. Nature Communications
- Triple‑negative breast cancer therapy: Current and future perspectives (Review)
- (2020) Kwang‑Ai Won et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk
- (2020) Deguang Kong et al. ONCOGENE
- VEGF/Neuropilin Signaling in Cancer Stem Cells
- (2019) Arthur Mercurio INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression
- (2019) Ameer L. Elaimy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data
- (2019) Naim Al Mahi et al. Scientific Reports
- Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
- (2018) Christopher J O'Conor et al. Biomarkers in Medicine
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
- (2018) Anh Le et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- VEGF–neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin
- (2018) Ameer L. Elaimy et al. Science Signaling
- Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
- (2018) Ameer L. Elaimy et al. Science Signaling
- Tumor Control Index as a new tool to assess tumor growth in experimental animals
- (2017) William L. Corwin et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer
- (2017) Leticia Varella et al. SEMINARS IN ONCOLOGY
- Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency
- (2016) Jasmine M. De Cock et al. CANCER RESEARCH
- Organoids: A historical perspective of thinking in three dimensions
- (2016) Marina Simian et al. JOURNAL OF CELL BIOLOGY
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Mechanism of early dissemination and metastasis in Her2+ mammary cancer
- (2016) Kathryn L. Harper et al. NATURE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling
- (2016) Yu-Wen Yeh et al. Oncotarget
- P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer
- (2016) Hira Lal Goel et al. Cell Reports
- Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
- (2016) Jingdan Qiu et al. Journal of Cancer
- ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
- (2015) Peijing Zhang et al. CELL CYCLE
- The Epithelial-Mesenchymal Transition and Cancer Stem Cells: Functional and Mechanistic Links
- (2015) Xiangqiang Liu et al. CURRENT PHARMACEUTICAL DESIGN
- VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin
- (2015) HAIPENG ZHU et al. Molecular Medicine Reports
- Structural Basis for VEGF-C Binding to Neuropilin-2 and Sequestration by a Soluble Splice Form
- (2015) Matthew W. Parker et al. STRUCTURE
- Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo
- (2015) Hironao Nakayama et al. Scientific Reports
- Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
- (2015) Gerald J Prud'homme et al. Oncotarget
- A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
- (2014) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF- 1-Induced Epithelial-Mesenchymal Transition
- (2013) P. Nasarre et al. CANCER RESEARCH
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
- (2013) Hira Lal Goel et al. EMBO Molecular Medicine
- Neuropilin-1Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
- (2012) Usman Yaqoob et al. CANCER RESEARCH
- Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
- (2012) Andrea Casazza et al. EMBO Molecular Medicine
- Bevacizumab and breast cancer: what does the future hold?
- (2012) Christina E Stevenson et al. Future Oncology
- Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
- (2012) Matthew W. Parker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuropilin-2 regulates 6 1 integrin in the formation of focal adhesions and signaling
- (2012) H. L. Goel et al. JOURNAL OF CELL SCIENCE
- Avastin Saga Reveals Debate Over Clinical Trial Endpoints
- (2012) S. P. Sharma JNCI-Journal of the National Cancer Institute
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3
- (2010) Yunling Xu et al. JOURNAL OF CELL BIOLOGY
- A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
- (2010) E. Geretti et al. MOLECULAR CANCER RESEARCH
- Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression
- (2009) Hironao Yasuoka et al. BMC CANCER
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
- (2008) Maresa Caunt et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now